Valuation: Laurus Labs Limited

Capitalization 559B 6.14B 5.24B 4.85B 4.56B 8.49B 9.11B 55.99B 22.12B 266B 23.03B 22.56B 970B P/E ratio 2026 *
76.7x
P/E ratio 2027 * 58.5x
Enterprise value 585B 6.42B 5.47B 5.07B 4.77B 8.88B 9.53B 58.56B 23.13B 278B 24.09B 23.6B 1,015B EV / Sales 2026 *
8.78x
EV / Sales 2027 * 7.64x
Free-Float
66.1%
Yield 2026 *
0.15%
Yield 2027 * 0.16%
More valuation ratios * Estimated data
Dynamic Chart
1 day-3.14%
1 week-8.02%
Current month-9.48%
1 month-5.75%
3 months+8.56%
6 months+20.92%
Current year-9.48%
More quotes
1 week 999
Extreme 999
1,096.9
1 month 999
Extreme 999
1,141
Current year 999
Extreme 999
1,141
1 year 501.15
Extreme 501.15
1,141
3 years 278.85
Extreme 278.85
1,141
5 years 278.85
Extreme 278.85
1,141
10 years 59
Extreme 59
1,141
More quotes
Manager TitleAgeSince
Chief Executive Officer 65 20/01/2006
Director of Finance/CFO - 29/11/2006
Chief Operating Officer - 01/04/2008
Director TitleAgeSince
Director/Board Member 65 20/01/2006
Director/Board Member 68 06/07/2016
Director/Board Member - 26/07/2016
More insiders
Change 5d. change 1-year change 3-years change Capi.($)
-3.26%-8.02%+73.86%+187.47% 6.14B
+0.28%-3.33%+43.48%+200.89% 932B
-0.21%+2.13%+48.41%+29.32% 526B
-0.14%-3.04%+24.76%+43.08% 378B
-0.23%+1.50%+29.64%+17.57% 374B
-2.66%-3.48%+25.25%+20.71% 282B
-1.12%+0.55%+28.05%+35.25% 278B
+0.57%+1.10%+11.77%-0.45% 272B
+3.17%+1.62%-29.35%-19.36% 272B
+0.18%+2.07%+21.64%+25.74% 178B
Average -0.49%-0.21%+27.75%+54.02% 349.79B
Weighted average by Cap. +0.02%-0.40%+28.84%+69.06%
See all sector performances

Financials

2026 *2027 *
Net sales 66.59B 732M 624M 578M 543M 1.01B 1.08B 6.67B 2.63B 31.66B 2.74B 2.69B 116B 76.65B 842M 718M 665M 626M 1.16B 1.25B 7.68B 3.03B 36.45B 3.16B 3.09B 133B
Net income 7.22B 79.33M 67.61M 62.64M 58.92M 110M 118M 723M 286M 3.43B 297M 291M 12.53B 9.54B 105M 89.35M 82.78M 77.86M 145M 155M 956M 378M 4.54B 393M 385M 16.56B
Net Debt 25.62B 281M 240M 222M 209M 389M 417M 2.57B 1.01B 12.18B 1.06B 1.03B 44.45B 26.28B 289M 246M 228M 214M 399M 428M 2.63B 1.04B 12.5B 1.08B 1.06B 45.61B
More financial data * Estimated data
Logo Laurus Labs Limited
Laurus Labs Limited is an India-based pharmaceutical and biotechnology company. The Company offers integrated portfolio of Active Pharma Ingredients (API) including intermediates, Generic Finished dosage forms (FDF) and Contract Research services to cater to the needs of the global pharmaceutical industry. It operates through four divisions: Generics API, Generics FDF, Laurus Synthesis, and Laurus Bio. The Generics API is a third-party API supplier for antiretrovirals. The Generic FDF business focuses on oral solid formulations. The Laurus Synthesis provides drug development and manufacturing services to global pharma, crop science, animal health, and others. The Laurus Bio offers comprehensive services from clone and strain engineering to production, supporting clients across the microbial precision fermentation spectrum. The Company operates through two geographical segments: Revenue from customers within India-Domestic, and Revenue from customers outside India-Exports.
Employees
6,167
More about the company
Date Price Change Volume
21/01/26 1,001.70 -3.26% 1,157,849
20/01/26 1,035.50 -2.56% 2,915,781
19/01/26 1,062.70 -1.31% 4,147,522
16/01/26 1,076.80 -1.26% 1,410,479
14/01/26 1,090.50 +3.04% 2,383,234

Delayed Quote NSE India S.E., January 21, 2026 at 06:13 am

More quotes
Trader
Investor
Global
Quality
ESG MSCI
BBB
More Ratings
Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
15
Last Close Price
1,035.50INR
Average target price
863.13INR
Spread / Average Target
-16.65%
Consensus

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Equities
  3. LAURUSLABS Stock